Safety and Efficacy of Cyberknife in Patients With Borderline Resectable or Locally Advanced Pancreatic Adenocarcinoma: Open Label Prospective Randomized Clinical Trial
The hypothesize that SBRT will limit or reverse tumor growth and thereby convert the borderline resectable disease or locally advanced disease in to a resectable tumor. Furthermore, we want to assess whether SBRT leads to an improved quality of life compared to IMRT.
100 项与 Capital Health System, Inc. 相关的临床结果
0 项与 Capital Health System, Inc. 相关的专利(医药)
100 项与 Capital Health System, Inc. 相关的药物交易
100 项与 Capital Health System, Inc. 相关的转化医学